title: Cardioplegia with adenosine and adenosine triphosphate in the isolated guinea pig heart.
abstract: In order to determine the effect of adenosine triphosphate (ATP) and adenosine in cardioplegic solutions, a comparative study has been undertaken in isolated guinea pig hearts using the Langendorff perfusion technique as a model of cardiopulmonary bypass. The hearts (n = 10 in each group) previously being perfused by Krebs-Henseleit solution, were arrested by one of the following cardioplegic solutions: 1) Potassium 20 mM/L (Plegisol), 2) Potassium 20 mM/L+ATP 10 mM/L, 3) Adenosine 10 mM/L, 4) Adenosine 10 mM/L+ATP 10 mM/L. After 45 min of hypothermic ischemia, postischemic recovery of heart rate, ventricular contractility, heart work and postischemic changes in tissue enzymes (LDH, SGOT, SGPT) were compared among the 4 different cardioplegic solutions. Arrest time and number of arrest beats were also recorded and compared among the groups. Although similar beneficial results on postischemic recovery were achieved with adenosine cardioplegia and with ATP supplemented potassium cardioplegia, ATP supplemented adenosine cardioplegia did not show any beneficial effects on postischemic recovery.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, Gazi University Medical School, Ankara, Turkey.
authors.forename: H
authors.initials: H
authors.lastname: Soncul
authors.forename: A
authors.initials: A
authors.lastname: Ersöz
authors.forename: L
authors.initials: L
authors.lastname: Gökgöz
authors.forename: C
authors.initials: C
authors.lastname: Karasu
authors.forename: K
authors.initials: K
authors.lastname: Ayrancioglu
authors.forename: V
authors.initials: V
authors.lastname: Sinci
authors.forename: M
authors.initials: M
authors.lastname: Altan
mesh_terms: D000241:Adenosine / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D002314:Cardioplegic Solutions / Q000494:pharmacology; D004338:Drug Combinations; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006323:Heart Arrest / Q000503:physiopathology; D006324:Heart Arrest, Induced; D066298:In Vitro Techniques; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D011188:Potassium / Q000494:pharmacology
chemical_list: D002314:Cardioplegic Solutions; D004338:Drug Combinations; D000255:Adenosine Triphosphate; D000241:Adenosine; D011188:Potassium